Table 1:
Group 1 (n = 19) | Group 2 (n = 13) | P-value | |
---|---|---|---|
Age (years) | 65.9 ± 12.4 | 61.4 ± 10.2 | 0.2019 |
Male | 11 (61.1) | 6 (60.0) | 0.2899 |
BMI (kg/m2) | 27.1 ± 4.9 | 24.99 ± 7.2 | 0.2646 |
Diabetes | 1 (5.5) | 3 (23.1) | 0.4420 |
Hypertension | 14 (77.78) | 8 (61.5) | 0.7889 |
Hyperlipidaemia | 14 (77.78) | 5 (38.5) | 0.3124 |
Smoking | 7 (38.89) | 6 (46.2) | 0.6309 |
COPD | 3 (16.67) | 2 (15.4) | 1.0000 |
PVD | 8 (44.44) | 6 (46.2) | 0.7248 |
Renal insufficiency | 0 | 1 (7.7) | 0.5882 |
Previous MI | 13 (72.22) | 4 (30.1) | 0.2160 |
Previous CABG | 3 (16.67) | 0 | 0.0441 |
Previous PCI | 5 (27.78) | 1 (7.7) | 0.0702 |
CCS >3 | 8 (44.44) | 6 (46.2) | 0.1027 |
3Vx | 3 (16.67) | 1 (7.7) | 0.354 |
LMCA | 9 (50.0) | 5 (38.5) | 0.986 |
Normal LVEF | 15 (83.3) | 8 (61.5) | 0.892 |
ASA | 3.33 ± 0.69 | 3.67 ± 0.5 | 0.6592 |
EuroSCORE | 10.16 ± 6.79 | 7.8 ± 7.6 | 0.125 |
Data are presented as mean ± SD or number (%).
ASA: American Society of Anaesthesiologists; BMI: body mass index (kg/m2); CABG: coronary artery bypass graft; CCS: Canadian Cardiovascular Society; COPD: chronic congestive pulmonary disease; LMCA: left main coronary artery; LVEF: left ventricular ejection fraction; MI: myocardial infarction; PCI: percutaneous coronary intervention; PVD: peripheral vascular disease; 3Vx: three vessels coronary artery disease.